Cite Filings / AVLN / 0001193125-26-212017

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Avalyn Pharma Inc. Filed 2026-05-07 Acc 0001193125-26-212017

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-11 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-08 SCHEDULE 13D Beneficial Ownership Report
2026-05-08 SCHEDULE 13D Beneficial Ownership Report
2026-05-07 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-05 4 10% owner bought 555,555 shares at $18.00 ($9,999,990)
2026-05-05 4 10% owner acquired 2,284,535 shares (conversion)
2026-05-05 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…